As a medical student and researcher, I was shocked by the brazen inequity of the trial.  Randomized controlled trials have ...

Patients with chronic kidney disease are often taken off RAS inhibitors after declines in kidney function, but the risks may ...

Multiple system atrophy (MSA) is an adult-onset, rapidly progressive neurodegenerative disorder characterised by the aggregation of α-synuclein in oligodendroglial cytoplasmatic inclusions.1 ...

At a Senate hearing on Wednesday, Robert F. Kennedy, Jr., referred to ibogaine as the most promising treatment for PTSD and ...

In October 2024, Calluna Pharma concluded the Phase I clinical study of its lead product, CAL101, for fibrotic and ...

The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

A newly published Cochrane systematic review examining amyloid-beta-targeting monoclonal antibodies in Alzheimer's disease ...

Spread the loveIntroduction In recent years, ultra-processed foods (UPFs) have become a staple in many diets, often hailed for their convenience and taste. However, increasing evidence has linked high ...

In this letter, we examine not one but three meta-analyses of randomized controlled trials to explore a provocative question: ...

A Mayo Clinic-led study found that high-dose vitamin D supplementation in inflammatory bowel disease (IBD) patients with low vitamin D levels was associated with increased protective IgA tagging and ...

In a new study published in Clinical Gastroenterology and Hepatology, the low FODMAP diet and the antibiotic rifaximin ...

One of the world's oldest medicines may have a powerful new purpose. A growing body of clinical evidence suggests that aspirin, the common painkiller with roots stretching back 4,000 years, can ...